1
|
Synthesis and Biological Evaluation of 2,3,4-Triaryl-1,2,4-oxadiazol-5-ones as p38 MAPK Inhibitors. Molecules 2021; 26:molecules26061745. [PMID: 33804659 PMCID: PMC8003627 DOI: 10.3390/molecules26061745] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2021] [Revised: 03/12/2021] [Accepted: 03/18/2021] [Indexed: 12/13/2022] Open
Abstract
A series of azastilbene derivatives, characterized by the presence of the 1,2,4-oxadiazole-5-one system as a linker of the two aromatic rings of stilbenes, have been prepared as novel potential inhibitors of p38 MAPK. Biological assays indicated that some of the synthesized compounds are endowed with good inhibitory activity towards the kinase. Molecular modeling data support the biological results showing that the designed compounds possess a reasonable binding mode in the ATP binding pocket of p38α kinase with a good binding affinity.
Collapse
|
2
|
New benzene dimers: a benchmark theoretical investigation. Theor Chem Acc 2020. [DOI: 10.1007/s00214-020-02684-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
3
|
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals (Basel) 2020; 13:ph13010008. [PMID: 31947889 PMCID: PMC7168938 DOI: 10.3390/ph13010008] [Citation(s) in RCA: 167] [Impact Index Per Article: 41.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Revised: 12/20/2019] [Accepted: 12/23/2019] [Indexed: 02/07/2023] Open
Abstract
It is over 50 years since the discovery of microtubules, and they have become one of the most important drug targets for anti-cancer therapies. Microtubules are predominantly composed of the protein tubulin, which contains a number of different binding sites for small-molecule drugs. There is continued interest in drug development for compounds targeting the colchicine-binding site of tubulin, termed colchicine-binding site inhibitors (CBSIs). This review highlights CBSIs discovered through diverse sources: from natural compounds, rational design, serendipitously and via high-throughput screening. We provide an update on CBSIs reported in the past three years and discuss the clinical status of CBSIs. It is likely that efforts will continue to develop CBSIs for a diverse set of cancers, and this review provides a timely update on recent developments.
Collapse
|
4
|
Darabi HR, Sobhani L, Rastgar S, Aghapoor K, Amini SK, Zadmard R, Jadidi K, Notash B. Synthesis, characterization and selective Cu2+ recognition of novel E– and Z–stilbenophanes. Supramol Chem 2018. [DOI: 10.1080/10610278.2018.1528010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Hossein Reza Darabi
- Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
| | - Leila Sobhani
- Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
| | - Saeed Rastgar
- Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
| | - Kioumars Aghapoor
- Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
| | - Saeed K. Amini
- Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
| | - Reza Zadmard
- Nano & Organic Synthesis Lab, Chemistry & Chemical Engineering Research Center of Iran, Tehran, Iran
| | - Khosrow Jadidi
- Department of Chemistry, Shahid Beheshti University, G.C. Tehran, Iran
| | - Behrouz Notash
- Department of Chemistry, Shahid Beheshti University, G.C. Tehran, Iran
| |
Collapse
|
5
|
Luo W, Tweedie D, Beedie SL, Vargesson N, Figg WD, Greig NH, Scerba MT. Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorg Med Chem 2018; 26:1547-1559. [PMID: 29472124 PMCID: PMC5891396 DOI: 10.1016/j.bmc.2018.01.032] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2017] [Revised: 01/22/2018] [Accepted: 01/31/2018] [Indexed: 02/07/2023]
Abstract
A library of 15 novel and heretofore uncharacterized adamantyl and noradamantyl phthalimidines was synthesized and evaluated for neuroprotective and anti-angiogenic properties. Phthalimidine treatment in LPS-challenged cells effected reductions in levels of secreted TNF-α and nitrite relative to basal amounts. The primary SAR suggests nitration of adamantyl phthalimidines has marginal effect on TNF-α activity but promotes anti-nitrite activity; thioamide congeners retain anti-nitrite activity but are less effective reducing TNF-α. Site-specific nitration and thioamidation provided phthalimidine 24, effecting an 88.5% drop in nitrite concurrent with only a 4% drop in TNF-α. Notable anti-angiogenesis activity was observed for 20, 21 and 22.
Collapse
Affiliation(s)
- Weiming Luo
- Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| | - David Tweedie
- Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| | - Shaunna L Beedie
- School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK; Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
| | - Neil Vargesson
- School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
| | - William D Figg
- Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
| | - Nigel H Greig
- Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
| | - Michael T Scerba
- Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| |
Collapse
|
6
|
Álvarez R, López V, Mateo C, Medarde M, Peláez R. p,p-Dihydroxydihydrostilbenophanes Related to Antimitotic Combretastatins. Conformational Analysis and Its Relationship to Tubulin Inhibition. J Org Chem 2014; 79:6840-57. [DOI: 10.1021/jo500798r] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Raquel Álvarez
- Laboratorio
de Química Orgánica y Farmacéutica, Facultad
de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL) and Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), E-37007 Salamanca, Spain
| | - Vilmarí López
- Laboratorio
de Química Orgánica y Farmacéutica, Facultad
de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | - Carmen Mateo
- Laboratorio
de Química Orgánica y Farmacéutica, Facultad
de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | - Manuel Medarde
- Laboratorio
de Química Orgánica y Farmacéutica, Facultad
de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL) and Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), E-37007 Salamanca, Spain
| | - Rafael Peláez
- Laboratorio
de Química Orgánica y Farmacéutica, Facultad
de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL) and Centro de Investigación de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), E-37007 Salamanca, Spain
| |
Collapse
|
7
|
Álvarez R, Puebla P, Díaz JF, Bento AC, García-Navas R, de la Iglesia-Vicente J, Mollinedo F, Andreu JM, Medarde M, Peláez R. Endowing Indole-Based Tubulin Inhibitors with an Anchor for Derivatization: Highly Potent 3-Substituted Indolephenstatins and Indoleisocombretastatins. J Med Chem 2013; 56:2813-27. [DOI: 10.1021/jm3015603] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Raquel Álvarez
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | - Pilar Puebla
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | | | - Ana C. Bento
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | - Rósula García-Navas
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | - Janis de la Iglesia-Vicente
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | - Faustino Mollinedo
- Instituto de Biología Molecular
y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, Campus Miguel de Unamuno,
E-37007 Salamanca, Spain
| | | | - Manuel Medarde
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | - Rafael Peláez
- Laboratorio de Química
Orgánica y Farmacéutica, CIETUS and IBSAL, Facultad
de Farmacia, Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| |
Collapse
|
8
|
Lu Y, Chen J, Xiao M, Li W, Miller DD. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res 2012; 29:2943-71. [PMID: 22814904 DOI: 10.1007/s11095-012-0828-z] [Citation(s) in RCA: 547] [Impact Index Per Article: 45.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2012] [Accepted: 07/05/2012] [Indexed: 12/13/2022]
Abstract
Tubulin dynamics is a promising target for new chemotherapeutic agents. The colchicine binding site is one of the most important pockets for potential tubulin polymerization destabilizers. Colchicine binding site inhibitors (CBSI) exert their biological effects by inhibiting tubulin assembly and suppressing microtubule formation. A large number of molecules interacting with the colchicine binding site have been designed and synthesized with significant structural diversity. CBSIs have been modified as to chemical structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers. CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin. The present review is a synopsis of compounds that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.
Collapse
Affiliation(s)
- Yan Lu
- Department of Pharmaceutical Sciences, Health Science Center, University of Tennessee, 847 Monroe Ave, Memphis, TN 38163, USA
| | | | | | | | | |
Collapse
|
9
|
Álvarez R, López V, Mateo C, Medarde M, Peláez R. New para-para Stilbenophanes: Synthesis by McMurry Coupling, Conformational Analysis and Inhibition of Tubulin Polymerisation. Chemistry 2011; 17:3406-19. [DOI: 10.1002/chem.201002869] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2010] [Indexed: 11/12/2022]
|
10
|
|
11
|
Mateo C, Alvarez R, Pérez-Melero C, Peláez R, Medarde M. Conformationally restricted macrocyclic analogues of combretastatins. Bioorg Med Chem Lett 2007; 17:6316-20. [PMID: 17889536 DOI: 10.1016/j.bmcl.2007.08.075] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2007] [Revised: 08/30/2007] [Accepted: 08/31/2007] [Indexed: 11/19/2022]
Abstract
New analogues of combretastatins have been evaluated as inhibitors of tubulin polymerization. These compounds present a macrocyclic structure, in which the para positions of the aromatic moieties have been linked by a 5- or 6-atoms chain, in order to produce a conformational restriction. This could contribute to determine the active conformation for these ligands. Such a conformational restriction and/or the steric hindrance makes them less potent inhibitors than the model compound CA-4.
Collapse
Affiliation(s)
- Carmen Mateo
- Laboratorio de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain
| | | | | | | | | |
Collapse
|
12
|
Mateo C, López V, Medarde M, Peláez R. Synthesis and Conformational Analysis of Macrocyclic Dihydroxystilbenes Linked between thepara–para Positions. Chemistry 2007; 13:7246-56. [PMID: 17566133 DOI: 10.1002/chem.200700323] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
A new family of diphenylethanes has been synthesized as conformationally restricted analogues of antimitotic combretastatins. The two phenyl rings are linked between the para-phenolic positions through a 3-oxapentamethylene or hexamethylene chain. The key macrocyclization step was achieved in moderate yields by using an intramolecular McMurry pinacol coupling of linked aromatic dialdehydes, except for the nitro-substituted compounds. The relative stereochemistry of the isomeric pinacols was determined by a combination of spectroscopic, chemical derivatization, and molecular-modeling approaches. The NMR spectra of these compounds (with a polyoxygenated crownophane skeleton) indicate severe conformational restrictions relative to their parent combretastatins; the rotation of the phenyl rings is hampered by interactions of their substituents and the linker and the conformational restrictions imposed by the substituted bridge.
Collapse
Affiliation(s)
- Carmen Mateo
- Laboratorio de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain
| | | | | | | |
Collapse
|
13
|
Herndon JW. The chemistry of the carbon–transition metal double and triple bond: Annual survey covering the year 2005. Coord Chem Rev 2007. [DOI: 10.1016/j.ccr.2006.11.002] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Tron GC, Pirali T, Sorba G, Pagliai F, Busacca S, Genazzani AA. Medicinal chemistry of combretastatin A4: present and future directions. J Med Chem 2006; 49:3033-44. [PMID: 16722619 DOI: 10.1021/jm0512903] [Citation(s) in RCA: 516] [Impact Index Per Article: 28.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Gian Cesare Tron
- Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center, Università degli Studi del Piemonte Orientale A. Avogadro, Via Bovio 6, 28100 Novara, Italy.
| | | | | | | | | | | |
Collapse
|